THE PSYCHOPARMACOTHERAPY SPECIFIC IN ONCOLOGY PATIENTS WITH ANXIETY DISORDERS

ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

https://doi.org/10.37469/0507-3758-2018-64-5-651-655

Published 01.05.2018

Tatyana Karavaeva⁺⁻
Anna Vasileva⁺⁻
Tatyana Semiglazova⁺⁻

Tatyana Karavaeva

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology of the Russian Federation Health Ministry, N.I. Petrov National Medical Research Center for Oncology of the Russian Federation Health Ministry, Saint Petersburg State University

Anna Vasileva

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology of the Russian Federation Health Ministry, I.I. Mechnikov North-western Medical State University

Tatyana Semiglazova

N.I. Petrov National Medical Research Center for Oncology of the Russian Federation Health Ministry, I.I. Mechnikov North-western Medical State University

##article.numberofdownloads## 154

##article.numberofviews## 259

PDF (Русский)

Keywords

ANXIETY
PSYCHOPHARMACOTHERAPY
NEUROTIC DISORDERS
ONCOLOGY COMORBID ANXIETY DISORDERS
PSYCHOPHARMACOTHERAPY ALGORITHM

How to Cite

Karavaeva, T., Vasileva, A., & Semiglazova, T. (2018). THE PSYCHOPARMACOTHERAPY SPECIFIC IN ONCOLOGY PATIENTS WITH ANXIETY DISORDERS. Voprosy Onkologii, 64(5), 651–655. https://doi.org/10.37469/0507-3758-2018-64-5-651-655

Abstract

There is a high incidence of the comorbid non-psychotic anxiety disorders in oncology patients. The choice of psychopharmacological treatment for this group of patients is a difficult task needing consideration of the complex of clinical psychosocial factors, peculiarities of the tumor process course, illness prognosis and pharmacological interactions. The article proposes the anxiolytic therapy algorithm, describes the psychopharmacological treatment in the framework od the complex healthcare services and oncology illnesses rehabilitation.

https://doi.org/10.37469/0507-3758-2018-64-5-651-655

##article.numberofdownloads## 154

##article.numberofviews## 259

PDF (Русский)

References

Караваева Т.А., Васильева А.В., Семиглазова Т.Ю., и др. Алгоритм диагностики тревожных расстройств невротического уровня у онкологических больных // Вопросы онкологии. - 2016. - № 2. - С. 355-360.

Лукошкина Е.П., Караваева Т.А., Васильева А.В. Этиология, эпидемиология и психотерапия сопутствующих психических расстройств при онкологических заболеваниях // Вопросы онкологии. - 2016. - № 6. - С. 774-783.

Рациональная фармакотерапия в психиатрической практике. (под общей редакцией Александровского Ю. А., Незнанова Н. Г - М.: ГЭОТАР-Медиа, 2014. -1080 с.

Самушия М.А., Мустафина Е.А. Нозогении (психогенные реакции) у женщин со злокачественными опухолями органов репродуктивной системы // Психические расстройства в общей медицине. - 2007. - № 3. - С. 11-16.

Семенова Н.В., Ляшковская С.В., Лысенко И.С., Чернов П.Д. Клинико-психологические особенности пациентов с онкологическими заболеваниями в период активного специализированного лечения в связи с задачами оказания психотерапевтической помощи. // Обозрение психиатрии и медицинской психологии. - 2018. - № 1. - С. 33-42.

Стрижаков А.Н., Подзолкова Н.М., Глазкова О.Л., Романова Е.Н. Грандаксин как возможная альтернатива заместительной гормональной терапии // Вестник -2000. - № 3. - С. 67-69.

Akechi T., Okamura H., Nishiwaki Y. et al. Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma. A longitudinal study // Cancer. - 2001. - Vol. 92. - P 2609-2622.

Bardwell W.A., Natarajan L. Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer // J.Clin Oncol. - 2006. - № 24. - P. 2420-2427.

Cowen PJ. New drugs, old problems. Revisiting. Pharmacological management of treatment-resistant depression // Advances in Psychiatric Treatment. - 2005. - Vol. 11. - Р 19-27.

Foldes-Busque G., Marchand A., Landry P. Early detection and treatment of panic disorder with or without agoraphobia: update // Can. Fam. Physician. - 2007. - Vol. 53. - № 10. - P 1686-1693.

Gil Moncayo F.L., Costa Requena G., Perez F.J. et al. Psychological adjustment and prevalence of psychiatric disorders in cancer patients // Med. Clin. (Bare). - 2008. - Vol. 130. - № 3. - Р 90-92.

Gil Nuno P, Albuquerque E., Vilao O. Use of psychotropic drugs in palliative cancer care: A retrospective Study // Abstracts of the 8th world congress of psycho-oncology. - 2006. - Vol. l5. - № 2. - P. 154.

Jacobsen PB., Donovan K.A., Trask P.C. et al. Screening for psychologic distress in ambulatory Cancer patients // Cancer. - 2005. - Vol. 103. - P. 1494-1502.

Kissane D.W., Doolittle M. Demoralization and Depression // Cancer In: Psycho-Oncology edited by Wise T.N., Biondi M., Costantini A. - American Psychiatric Association. - 2013. - P. 99-102.

Manne S.L., Pape S.J. Functional impairment, marital quality, and patient psychological distress as predictors of psychological distress among cancer patients' spouses // Health Psychol. - 2001. - № 20. - P 452457.

Miller K, Massie M.J. Depression and anxiety // Cancer J. - 2006. - Vol. 12. - P. 388-439.

Montgomery Ch., Pocock M., Titley K. et al. Predicting psychological distress in patients with leukaemia and lymphoma // General Hospital Psychiatry. - 2007. - Vol. 29. - № 3. - P. 251-256.

Rahola J.G. Somatic drugs for psychiatric diseases: Aspirin or simvastatin for depression? // Current Neuropharmacology. - 2012. - Vol. 10(2). - P. 139-158.

Romera I., Furnandez-Purez S., Montego B.L. et al. Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: prevalence of painful somatic symptoms, functioning and health status // J. Affect. Disord. - 2010. - Vol. 127. - P. 160-168.

Strong V. Waters R., Hibberd C. Emotional distress in cancer patients: the Edinburgh cancer centersymptom study // Br.J. Cancer. - 2007. - № 96. - P. 868-874.

Turk C.L., Heimberg R.G., Luterek J.A. et al. Emotion dysregulation in generalized anxiety disorder: a comparison with social anxiety disorder // Cognitive Therapy and Research. -2005. - Vol. 29. - P. 89-106.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Tatyana Semiglazova, Yevgeniya Tsyrlina, Artem Poltoratskiy, Yekaterina Busko, Vladislav Semiglazov, Anna Artemeva, Sergey Ivanov, Lev Bershteyn, Vladimir Anisimov, Aleksey Belyaev, Vladimir Semiglazov, V. Kostorov, Aleksey Novik, Boris Kasparov, Mikhail Osipov, Petr Krivorotko, Veronika Klimenko, Garik Dashyan, Ruslan Paltuev, Yelena Zhiltsova, Tengiz Tabagua, Aleksandr Komyakhov, Kirill Nikolaev, Viktoriya Bashlyk, Roman Donskikh, V. Apollonova, MELATONIN AND METFORMIN IN NEOADJUVANT HORMONOTHERAPY IN LOCALLY ADVANCED BREAST CANCER , Voprosy onkologii : Vol. 64 No. 5 (2018)
Boris Kasparov, Tatyana Semiglazova, Denis Kovlen, Gennadiy Ponomarenko, Valeriya Klyuge, Anton Krutov, Vladislav Osetnik, M. Tynkasova, Kristina Kondrateva, O. Zaozerskiy, Vladislav Semiglazov, A. Nosov, Aleksey Belyaev, REHABILITATION OF PATIENTS WITH PROSTATE CANCER , Voprosy onkologii : Vol. 66 No. 2 (2020)
Valentina Chulkova, Yelena Pestereva, Elvira Karpova, Nelli Khrustaleva, Tatyana Semiglazova, M. Rogachev, Aleksey Belyaev, EMOTIONAL BURNOUT AND ISSUES OF PROFESSIONAL PSYCHOLOGICAL TRAINING OF ONCOLOGISTS , Voprosy onkologii : Vol. 66 No. 2 (2020)
Mariia Urezkova , Tatyana Semiglazova , Anna Artemyeva , Asel Kudaybergenova , Vladislav Semiglazov , Petr Krivorotko, Vladimir Semiglazov , Results of FISH study of HER2 in triple-positive breast cancer , Voprosy onkologii : Vol. 69 No. 2 (2023)
Valentina Chulkova, Yelena Pestereva, Taras Popov, Anatoliy Yalov, Tatyana Semiglazova, D. Rysenkova, ATTITUDE OF CANCER PATIENTS TO TREATMENT AT SYSTEMIC THERAPY METHODS , Voprosy onkologii : Vol. 64 No. 3 (2018)
Valentina Chulkova, Tatyana Semiglazova, Margarita Vagaytseva, Andrey Karitskiy, Yevgeniy Demin, Viktoriya Fedorova, Yelena Pestereva, Aleksey Belyaev, K. Kondrateva, PSYCHOLOGICAL REHABILITATION AND SCREENING OF EMOTIONAL STRESS IN CANCER PATIENTS , Voprosy onkologii : Vol. 63 No. 2 (2017)
Yevgeniya Kharchenko, Tatyana Semiglazova, Anna Artemeva, Galina Kireeva, I. Polyatskin, Ilya Zyuzgin, Larisa Filatova, Yuliya Chudinovskikh, Margarita Motalkina, Yuliya Oleynik, PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL AND MOLECULAR GENETIC MARKERS IN DIFFUSE LARGE B-CELL LYMPHOMA , Voprosy onkologii : Vol. 66 No. 1 (2020)
Denis Fedyaev, V. Ignateva, Yelena Derkach, Sergey Zyryanov, Konstantin Laktionov, Tatyana Semiglazova, COMPARATIVE PHARMACOECONOMIC EVALUATION OF THE USE OF AFATINIB AND GEFITINIB IN THERAPY FOR LUNG CANCER , Voprosy onkologii : Vol. 63 No. 1 (2017)
Igor Berlev, Yekaterina Nekrasova, Gayk Mkrtchyan, Yevgeniya Bezhanova, Katran Guseynov, Yelena Ulrikh, Viktoriya Bashlyk, Anna Artemeva, Tatyana Semiglazova, Aleksandra Kondakova, Andrey Mishchenko, Nikolay Mikaya, Adiliya Urmancheeva, Nikolay Bondarev, O. Smirnova, DOSE-INTENSIVE NEOADJUVANT CHEMOTHERAPY IN COMBINED TREATMENT FOR LOCALLY ADVANCED CERVICAL CANCER: THE EXPERIENCE AND PERSPECTIVES , Voprosy onkologii : Vol. 63 No. 4 (2017)
Vladimir Semiglazov, Ye. Trufanova, Pavel Krzhivitskiy, Aleksey Belyaev, Aleksandra Kondakova, Sergey Yereshchenko, Yelena Zhiltsova, Andrey Mishchenko, Viktoriya Bashlyk, Asel Kudaybergenova, Veronika Klimenko, Anna Artemeva, Vladislav Semiglazov, Yekaterina Busko, Aleksandr Komyakhov, Tatyana Semiglazova, Garik Dashyan, Petr Krivorotko, A. Tseluyko, CLINICAL AND BIOLOGICAL MODEL FOR EVALUATION OF THE EFFECTIVENESS OF SYSTEMIC THERAPY FOR BREAST CANCER , Voprosy onkologii : Vol. 64 No. 3 (2018)

1 2 3 > >>